Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Nippon Shinyaku Co. Ltd.
DescriptionAntipruritic agent
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDermatitis
Indication DetailsTreat pruritus associated with atopic dermatitis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today